Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study

BACKGROUND: To examine the efficacy of lisdexamfetamine dimesylate (LDX) in adults with attention-deficit/hyperactivity disorder (ADHD) who remained symptomatic (ADHD Rating Scale IV [ADHD-RS-IV] total score >18) on amphetamine (AMPH) therapy (mixed AMPH salts and/or d-AMPH formulations) prior to...

Descripción completa

Detalles Bibliográficos
Autores principales: Babcock, Thomas, Dirks, Bryan, Adeyi, Ben, Scheckner, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554536/
https://www.ncbi.nlm.nih.gov/pubmed/23254273
http://dx.doi.org/10.1186/2050-6511-13-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554536/
https://www.ncbi.nlm.nih.gov/pubmed/23254273
http://dx.doi.org/10.1186/2050-6511-13-18

Ejemplares similares